Giuseppe Banna, Consultant Medical Oncologist at Portsmouth Hospitals University NHS Trust, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Bispecific T-cell Engagers are redefining the fight against urological cancers.
Our new comprehensive review is live in Critical Reviews in Oncology/Hematology!
This represents another fantastic achievement by Aruni Ghose and a spectacular team of excellent international colleagues.
We unpack how BiTEs act as a ‘bridge,’ directly engaging T-cells to destroy tumours with remarkable precision, offering new hope for prostate, bladder, renal, and testicular cancers.
The Bottom Line:
- A powerful new weapon against treatment-resistant cancers.
- Potential to turn ‘cold’ tumours ‘hot.’
- Active clinical development is showing promising efficacy.
Honoured to have collaborated with such a brilliant team including Jeremy Teoh, Yüksel ÜRÜN, Sara Elena Rebuzzi, Stergios Boussios on this transformative topic.”
Title: Unlocking precision: Bispecific T cell engagers and the next frontier in uro-oncology
Authors: Joecelyn Tan, Sri Vidya Gullapalli, Pratima Chapagain, Aruni Ghose, Armand Grollemund, Alex Speechley, Maryam Hasanova, Sayali Shinde, Advaith Kandala, Akash Maniam, Ankit Jain, Sola Adeleke, Sara Rebuzzi, Jeremy Teoh, Yüksel Ürün, Giuseppe Banna, Stergios Boussios
Read the Full Article on Critical Reviews in Oncology/Hematology
More posts featuring Giuseppe Banna.
